MR1 and infection: An intranasal infection of Francisella tularensis live-vaccine strain (LVS) in wild-type and MR1 KO mice, has also established that CD161++TCRvα7.2+ T cells have a direct early antibacterial effect in the lung and a sustained impact on development of effective adaptive mucosal immune response (10).